India to Iraq: Pioglitazone Export Trade Route
India has recorded 92 verified shipments of Pioglitazone exported to Iraq, representing a combined trade value of $820.5K USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $8.9K USD. The leading Indian exporter is AJANTA PHARMA LIMITED, which accounts for 91% of total export value with 19 shipments worth $745.2K USD. On the buying side, HAWKARY PHARMACEUITCAL CO.* is the largest importer in Iraq with $382.6K USD in purchases. The top 3 suppliers — AJANTA PHARMA LIMITED, AJANTA PHARMA LIMITED , INTACT DRUGS PHARMACEUTICALS PRIVATE LIMITED — together control 96% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Iraq Pioglitazone corridor is one of India's established pharmaceutical export routes, with 92 shipments documented worth a combined $820.5K USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 91% of all export value, reflecting the consolidated nature of India's pioglitazone manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $8.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with pioglitazone's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 25.7%, placing it at rank #18 among India's top pioglitazone export destinations globally.
On the import side, key buyers of Indian pioglitazone in Iraq include HAWKARY PHARMACEUITCAL CO.*, Al-Thuraya Scientific Drug Bureau, HAWKARY PHARMACEUITCAL CO and 14 others. HAWKARY PHARMACEUITCAL CO.* is the single largest importer with 10 shipments valued at $382.6K USD.
Route Characteristics
- Average transit31 days
- Peak seasonQ4
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#18
- Annual growth+25.7%
- Demand growth+21.6%
- Regulatory ease87/100
Top 10 Indian Pioglitazone Exporters to Iraq
Showing top 10 of 11 Indian suppliers exporting Pioglitazone to Iraq, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AJANTA PHARMA LIMITED Avg $39.2K per shipment | 19 | $745.2K | 90.8% |
| 2 | AJANTA PHARMA LIMITED Avg $30.4K per shipment | 1 | $30.4K | 3.7% |
| 3 | INTACT DRUGS PHARMACEUTICALS PRIVATE LIMITED Avg $7.8K per shipment | 2 | $15.6K | 1.9% |
| 4 | RAVI PHARMA Avg $482 per shipment | 20 | $9.6K | 1.2% |
| 5 | KWALITY PHARMACEUTICALS LIMITED Avg $2.6K per shipment | 3 | $7.8K | 1.0% |
| 6 | SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED Avg $423 per shipment | 15 | $6.3K | 0.8% |
| 7 | INTHERA PHARMAMED BIOTECH PRIVATE LIMITED Avg $675 per shipment | 3 | $2.0K | 0.2% |
| 8 | ZEAL PHARMA Avg $645 per shipment | 2 | $1.3K | 0.2% |
| 9 | SHREE RAJESHWAR PHARMA Avg $66 per shipment | 19 | $1.2K | 0.2% |
| 10 | SHREE RAJESHWAR PHARMA Avg $122 per shipment | 7 | $856 | 0.1% |
This table shows the top 10 of 11 Indian companies exporting pioglitazone to Iraq, ranked by total trade value. The listed exporters are: AJANTA PHARMA LIMITED, AJANTA PHARMA LIMITED , INTACT DRUGS PHARMACEUTICALS PRIVATE LIMITED, RAVI PHARMA, KWALITY PHARMACEUTICALS LIMITED, SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED, INTHERA PHARMAMED BIOTECH PRIVATE LIMITED, ZEAL PHARMA, SHREE RAJESHWAR PHARMA, SHREE RAJESHWAR PHARMA . AJANTA PHARMA LIMITED is the dominant supplier with 19 shipments worth $745.2K USD, giving it a 91% market share. The top 3 suppliers together account for 96% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to Iraq Pioglitazone export route.
Top 10 Pioglitazone Importers in Iraq
Showing top 10 of 17 known buyers in Iraq receiving Pioglitazone shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pioglitazone in Iraq include HAWKARY PHARMACEUITCAL CO.*, Al-Thuraya Scientific Drug Bureau, HAWKARY PHARMACEUITCAL CO, SHAMS AL-THURAYA CO FOR GENERAL TRA, HAWKARY PHARMACEUITCAL CO.* , among 17 total buyers. The largest importer is HAWKARY PHARMACEUITCAL CO.*, accounting for $382.6K USD across 10 shipments — representing 47% of all pioglitazone imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HAWKARY PHARMACEUITCAL CO.* | 10 | $382.6K | 46.6% |
| 2 | Al-Thuraya Scientific Drug Bureau | 4 | $181.7K | 22.1% |
| 3 | HAWKARY PHARMACEUITCAL CO | 2 | $85.3K | 10.4% |
| 4 | SHAMS AL-THURAYA CO FOR GENERAL TRA | 1 | $46.1K | 5.6% |
| 5 | HAWKARY PHARMACEUITCAL CO.* | 1 | $30.4K | 3.7% |
| 6 | SHAMS AL THURAYA CO FOR GENERAL TRA | 1 | $27.1K | 3.3% |
| 7 | SHAMS AL-THURAYA CO FOR GENERAL | 1 | $22.4K | 2.7% |
| 8 | DASH EXPRESS INTERNATIONAL SHIPPING | 2 | $15.6K | 1.9% |
| 9 | SKIN LINE LOGISTIC | 40 | $14.2K | 1.7% |
| 10 | AL RASEEN SCIENTIFIC BUREAU | 3 | $7.8K | 1.0% |
Showing top 10 of 17 Pioglitazone importers in Iraq on this route.
Top 10 Pioglitazone Formulations Imported by Iraq
Showing top 10 of 55 product formulations shipped on the India to Iraq Pioglitazone route, ranked by trade value
Iraq imports a wide range of pioglitazone formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SHIPMENT UNDER CONSIGNMENT SALE:GLYDYL MTABLETS 15/850MG[13920PACx3X10=417600TAB]PIOGLITAZONE AND METFORMIN HYDROCHLORI — accounts for $100.4K USD across 1 shipments. There are 55 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SHIPMENT UNDER CONSIGNMENT SALE:GLYDYL MTABLETS 15/850MG[13920PACx3X10=417600TAB]PIOGLITAZONE AND METFORMIN HYDROCHLORI | 1 | $100.4K | 12.2% |
| 2 | SHIPMENT UNDER CONSIGNMENTSALE:GLYDYL M15/500MG TABLETS[13355 X 3 X 10 = 400650TABLETS][PIOGLITAZONE AND METFORMIN HYD | 3 | $81.4K | 9.9% |
| 3 | TIBAN P 20/30 TABLETS [TENELIGLIPTIN 20MG AND PIOGLITAZONE 30 MG TABLETS] [6465X 3 X 10 = 193950 TABLETS] CONT AS PERNOS | 1 | $62.3K | 7.6% |
| 4 | TIBAN P 20/30 TABLETS[TENELIGLIPTIN 20 MG AND PIOGLITAZONE 30 MG TABLETS] [6375X 3 X 10=191250TABLETS]CONT AS PER INVOINOS | 1 | $61.5K | 7.5% |
| 5 | TIBAN P 20/30 TABLETS[6440 X 3 X 10 = 193200 TABLETS][TENELIGLIPTIN 20 MG AND PIOGLITAZONE 30 MG TABLETS]CONT:AS PER INV | 1 | $61.2K | 7.5% |
| 6 | TIBAN P 20 30 TABLETS TENELIGLIPTIN 20 MG AND PIOGLITAZONE 30 MG TABLETS 6351PACx3x19 190530 TABS CONT AS PER INVOICE | 1 | $60.4K | 7.4% |
| 7 | TIBAN P 20/15 TABLETS[TENELIGLIPTIN 20 MG AND PIOGLITAZONE 15 MG TABS][6355PACKx3x10=190650 TABS]EACH FILM AS PER INV | 1 | $49.2K | 6.0% |
| 8 | GLYDYL M 15/500MG TABLETS [PIOGLITAZONEAND METFORMIN HYDROCHLORIDE TABLETS USP15 / 500 MG]CONT AS PER INVOICE | 1 | $46.1K | 5.6% |
| 9 | TIBAN P 20/30 TABLETS[TENELIGLIPTIN 20 MG AND PIOGLITAZONE 30 MG TABLETS][3156 X3 X 10 = 94680 TABLETS] CONT:AS PER INV | 1 | $30.4K | 3.7% |
| 10 | TIBAN P 20/30 TABLETS [TENELIGLIPTIN 20MG AND PIOGLITAZONE 30 MG TABS][3100PACKx3x10=93000 TABS]EACH FILM AS PER INV | 1 | $29.3K | 3.6% |
Showing top 10 of 55 Pioglitazone formulations imported by Iraq on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 83%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 22 shipments. Transit time averages 31 days by sea.
Market Dynamics
India's pioglitazone exports to Iraq are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 19 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Iraq benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AJANTA PHARMA LIMITED, AJANTA PHARMA LIMITED , INTACT DRUGS PHARMACEUTICALS PRIVATE LIMITED — together account for 96% of total trade value on this route. The average shipment value of $8.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as shipment under consignmentsale:glydyl m15/500mg tablets[13355 x 3 x 10 = 400650tablets][pioglitazone and metformin hyd and tiban p 20/30 tablets [teneligliptin 20mg and pioglitazone 30 mg tablets] [6465x 3 x 10 = 193950 tablets] cont as pernos, suggesting that buyers in Iraq tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, HAWKARY PHARMACEUITCAL CO.* is the largest importer with 10 shipments worth $382.6K USD — representing 47% of all pioglitazone imports from India on this route. A total of 17 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $820.5K
- Avg. Shipment
- $8.9K
- Suppliers
- 11
- Buyers
- 17
- Transit (Sea)
- ~31 days
- Annual Growth
- +25.7%
Related Analysis
Other Pioglitazone Routes
Unlock the Full India to Iraq Pioglitazone Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 92 shipments on this route.
Frequently Asked Questions — India to Iraq Pioglitazone Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pioglitazone to Iraq?
The leading Indian exporters of Pioglitazone to Iraq are AJANTA PHARMA LIMITED, AJANTA PHARMA LIMITED , INTACT DRUGS PHARMACEUTICALS PRIVATE LIMITED. AJANTA PHARMA LIMITED holds the largest market share at approximately 91% of total trade value on this route.
Q What is the total value of Pioglitazone exports from India to Iraq?
India exports Pioglitazone to Iraq worth approximately $820.5K USD across 92 recorded shipments. The average value per shipment is $8.9K USD.
Q Which ports does India use to ship Pioglitazone to Iraq?
The most active port of origin is DELHI AIR with 22 shipments. Indian exporters primarily use sea freight for this route, with 83% of shipments going by sea and 28% by air.
Q How long does shipping take from India to Iraq for Pioglitazone?
The average transit time for Pioglitazone shipments from India to Iraq is approximately 31 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Iraq Pioglitazone trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.7% with demand growth tracking at 21.6%. The route is ranked #18 among India's top Pioglitazone export destinations globally.
Q How many suppliers are active on the India to Iraq Pioglitazone route?
There are currently 11 active Indian suppliers exporting Pioglitazone to Iraq. The market is moderately concentrated with AJANTA PHARMA LIMITED accounting for 91% of total shipment value.
Q Who are the main importers of Pioglitazone from India in Iraq?
The leading importers of Indian Pioglitazone in Iraq include HAWKARY PHARMACEUITCAL CO.*, Al-Thuraya Scientific Drug Bureau, HAWKARY PHARMACEUITCAL CO, SHAMS AL-THURAYA CO FOR GENERAL TRA, HAWKARY PHARMACEUITCAL CO.* . HAWKARY PHARMACEUITCAL CO.* is the largest buyer with 10 shipments worth $382.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Iraq export trade corridor identified from Indian Customs (DGFT) records for Pioglitazone.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 17 importers in Iraq matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 92 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
92 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists